Terms: = Breast cancer AND LCP1, CP64, 3936, ENSG00000136167, FLJ39956, DKFZp781A23186, L-PLASTIN, FLJ25423, P13796, FLJ26114, PLS2, LC64P
36 results:
1. Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden.
Justo N; Wilking N; Jönsson L
Clin Drug Investig; 2023 Jul; 43(7):529-540. PubMed ID: 37422544
[TBL] [Abstract] [Full Text] [Related]
2. The Impact of Limited Language Proficiency in Screening for breast cancer.
Cataneo JL; Meidl H; Ore AS; Raicu A; Schwarzova K; Cruz CG
Clin Breast Cancer; 2023 Feb; 23(2):181-188. PubMed ID: 36635166
[TBL] [Abstract] [Full Text] [Related]
3. Improving breast cancer diagnostics with deep learning for MRI.
Witowski J; Heacock L; Reig B; Kang SK; Lewin A; Pysarenko K; Patel S; Samreen N; Rudnicki W; Łuczyńska E; Popiela T; Moy L; Geras KJ
Sci Transl Med; 2022 Sep; 14(664):eabo4802. PubMed ID: 36170446
[TBL] [Abstract] [Full Text] [Related]
4. Targeted proteomics using parallel reaction monitoring confirms salivary proteins indicative of metastatic triple-negative breast cancer.
Giri K; Maity S; Ambatipudi K
J Proteomics; 2022 Sep; 267():104701. PubMed ID: 35995384
[TBL] [Abstract] [Full Text] [Related]
5. l-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness.
Machado RAC; Stojevski D; De Landtsheer S; Lucarelli P; Baron A; Sauter T; Schaffner-Reckinger E
Cell Commun Signal; 2021 Feb; 19(1):22. PubMed ID: 33618712
[TBL] [Abstract] [Full Text] [Related]
6. Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium.
Boulouard F; Kasper E; Buisine MP; Lienard G; Vasseur S; Manase S; Bahuau M; Barouk Simonet E; Bubien V; Coulet F; Cusin V; Dhooge M; Golmard L; Goussot V; Hamzaoui N; Lacaze E; Lejeune S; Mauillon J; Beaumont MP; Pinson S; Tlemsani C; Toulas C; Rey JM; Uhrhammer N; Bougeard G; Frebourg T; Houdayer C; Baert-Desurmont S
Clin Genet; 2021 May; 99(5):662-672. PubMed ID: 33454955
[TBL] [Abstract] [Full Text] [Related]
7. Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines.
Bremmer F; Bohnenberger H; Küffer S; Oellerich T; Serve H; Urlaub H; Strauss A; Maatoug Y; Behnes CL; Oing C; Radzun HJ; Ströbel P; Balabanov S; Honecker F
Dis Markers; 2019; 2019():8298524. PubMed ID: 31565104
[TBL] [Abstract] [Full Text] [Related]
8. Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral cancer.
Koide N; Kasamatsu A; Endo-Sakamoto Y; Ishida S; Shimizu T; Kimura Y; Miyamoto I; Yoshimura S; Shiiba M; Tanzawa H; Uzawa K
Sci Rep; 2017 Feb; 7():43379. PubMed ID: 28230172
[TBL] [Abstract] [Full Text] [Related]
9. l-plastin Ser5 phosphorylation in breast cancer cells and in vitro is mediated by RSK downstream of the ERK/MAPK pathway.
Lommel MJ; Trairatphisan P; Gäbler K; Laurini C; Muller A; Kaoma T; Vallar L; Sauter T; Schaffner-Reckinger E
FASEB J; 2016 Mar; 30(3):1218-33. PubMed ID: 26631483
[TBL] [Abstract] [Full Text] [Related]
10. Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis.
Vici P; Di Benedetto A; Ercolani C; Pizzuti L; Di Lauro L; Sergi D; Sperati F; Terrenato I; Dattilo R; Botti C; Fabi A; Ramieri MT; Mentuccia L; Marinelli C; Iezzi L; Gamucci T; Natoli C; Vitale I; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
Oncotarget; 2015 Dec; 6(40):42773-80. PubMed ID: 26544894
[TBL] [Abstract] [Full Text] [Related]
11. GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.
Inaguma S; Riku M; Ito H; Tsunoda T; Ikeda H; Kasai K
Oncotarget; 2015 Oct; 6(32):33648-57. PubMed ID: 26413813
[TBL] [Abstract] [Full Text] [Related]
12. Proteotranscriptomic Profiling of 231-BR breast cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.
Dun MD; Chalkley RJ; Faulkner S; Keene S; Avery-Kiejda KA; Scott RJ; Falkenby LG; Cairns MJ; Larsen MR; Bradshaw RA; Hondermarck H
Mol Cell Proteomics; 2015 Sep; 14(9):2316-30. PubMed ID: 26041846
[TBL] [Abstract] [Full Text] [Related]
13. Early (<10 mm) HER2-Positive Invasive breast Carcinomas are Associated with Extensive Diffuse High-Grade DCIS: Implications for Preoperative Mapping, Extent of Surgical Intervention, and Disease-Free Survival.
Tot T
Ann Surg Oncol; 2015 Aug; 22(8):2532-9. PubMed ID: 25582746
[TBL] [Abstract] [Full Text] [Related]
14. General supplement use, subsequent use and cancer risk in the UK Women's Cohort Study.
Hutchinson J; Burley VJ; Greenwood DC; Cade JE
Eur J Clin Nutr; 2014 Oct; 68(10):1095-100. PubMed ID: 24801368
[TBL] [Abstract] [Full Text] [Related]
15. Quantitative kinetic study of the actin-bundling protein l-plastin and of its impact on actin turn-over.
Al Tanoury Z; Schaffner-Reckinger E; Halavatyi A; Hoffmann C; Moes M; Hadzic E; Catillon M; Yatskou M; Friederich E
PLoS One; 2010 Feb; 5(2):e9210. PubMed ID: 20169155
[TBL] [Abstract] [Full Text] [Related]
16. The actin filament cross-linker l-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner.
Janji B; Vallar L; Al Tanoury Z; Bernardin F; Vetter G; Schaffner-Reckinger E; Berchem G; Friederich E; Chouaib S
J Cell Mol Med; 2010 Jun; 14(6A):1264-75. PubMed ID: 19799649
[TBL] [Abstract] [Full Text] [Related]
17. Identification of differentially expressed proteins in triple-negative breast carcinomas using DIGE and mass spectrometry.
Schulz DM; Böllner C; Thomas G; Atkinson M; Esposito I; Höfler H; Aubele M
J Proteome Res; 2009 Jul; 8(7):3430-8. PubMed ID: 19485423
[TBL] [Abstract] [Full Text] [Related]
18. Cataracts among cancer survivors.
Stava C; Beck M; Vassilopoulou-Sellin R
Am J Clin Oncol; 2005 Dec; 28(6):603-8. PubMed ID: 16317272
[TBL] [Abstract] [Full Text] [Related]
19. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract] [Full Text] [Related]
20. Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy.
Liu Y; Ye T; Maynard J; Akbulut H; Deisseroth A
Cancer Gene Ther; 2006 Apr; 13(4):346-56. PubMed ID: 16179927
[TBL] [Abstract] [Full Text] [Related]
[Next]
